<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="15bde7a5-7e9f-4054-84b8-196a1c4c596b"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Billie Holiday — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="19480427120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="1db644cf-b4a3-4c7e-adda-7ed8008a7eba"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="ab7c672c-0a82-4ffa-b914-526fa80857e6" extension="HR-ML010-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-10-4472"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Billie</given><family>Holiday</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19150407"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="19480427120000-0500"/>
    <assignedAuthor><id root="b34260af-7fd8-4064-b9d9-7e7862452264"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Constance</given><family>Mayfield</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="19480427120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="b34260af-7fd8-4064-b9d9-7e7862452264"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Constance</given><family>Mayfield</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="19480427"/><high value="19480427"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="b34260af-7fd8-4064-b9d9-7e7862452264"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Constance</given><family>Mayfield</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="8aec7b6e-bcb1-4cda-9ff4-143c783f02ff"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>One-week buprenorphine check and addiction medicine consultation</originalText></code>
      <effectiveTime><low value="19480427"/><high value="19480427"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="b34260af-7fd8-4064-b9d9-7e7862452264"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Constance</given><family>Mayfield</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>One-week buprenorphine check, seen the same day by addiction medicine. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Holiday returns one week after starting buprenorphine with naloxone and is seen by Dr. Ortiz of addiction medicine on the same day. She took half a film on the first day and one film daily since, under the tongue each morning, without missing a dose. She has used no heroin or other opioids. She had no withdrawal, but cravings come back each evening, most of all after a show. She has had mild constipation and no drowsiness. She picked up two naloxone two-packs; her friend came with her and was shown how to use them. She is still drinking four or five drinks on performance nights. She read her results from last week by phone. She says she came back because nobody lectured her at the first visit. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Buprenorphine</td><td>8 mg daily for six days, every dose taken</td></tr><tr><td>Opioid use</td><td>None</td></tr><tr><td>Cravings</td><td>Every evening, strongest after shows</td></tr><tr><td>Side effects</td><td>Mild constipation</td></tr><tr><td>Naloxone</td><td>Two two-packs dispensed; her friend trained</td></tr><tr><td>Alcohol</td><td>Four or five drinks on performance nights</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No sweats, chills, or drowsiness</td></tr><tr><td>Gastrointestinal</td><td>Positive</td><td>Mild constipation; no nausea, vomiting, or abdominal pain</td></tr><tr><td>Psychiatric</td><td>Positive</td><td>Evening cravings; mood low at times; no thoughts of suicide or self-harm</td></tr></tbody></table><paragraph>3 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Buprenorphine 8 mg and naloxone 2 mg sublingual film: half a film (4 mg) on day 1, then one film (8 mg) under the tongue daily</td><td>One film under the tongue daily after a 4 mg first dose</td><td>Sublingual route</td><td>1948-04-20 to 1948-04-27</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Buprenorphine 8 mg and naloxone 2 mg sublingual film, two films (16 mg) under the tongue once daily</td><td>Two films under the tongue once daily</td><td>Sublingual route</td><td>1948-04-27</td><td>active</td><td>S</td></tr><tr ID="medication-3"><td>Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils; call 911</td><td>One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no response</td><td>Nasal route</td><td>1948-04-20</td><td>active</td><td>S</td></tr><tr ID="medication-4"><td>Acamprosate 333 mg delayed-release oral tablet, two tablets (666 mg) by mouth three times daily</td><td>Two tablets by mouth three times daily</td><td>Oral route</td><td>1948-04-27</td><td>active</td><td>S</td></tr><tr ID="medication-5"><td>Thiamine 100 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>1948-04-20 to 1948-10-19</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="eee3cf76-3411-404b-8a7c-86a24199cb0d"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19480420"/><high value="19480427"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38300" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Sublingual route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1010604" codeSystem="2.16.840.1.113883.6.88" displayName="buprenorphine 8 MG / naloxone 2 MG Sublingual Film"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="d283a7ca-d0e7-47eb-a40c-b4ce8727afd1"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F11.20" codeSystem="2.16.840.1.113883.6.90" displayName="Opioid dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="e0f50a80-2246-418c-8a58-5b6a2f8d3270"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19480427"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38300" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Sublingual route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1010604" codeSystem="2.16.840.1.113883.6.88" displayName="buprenorphine 8 MG / naloxone 2 MG Sublingual Film"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="1fe34c01-be6c-42fd-9461-b1df68fdcce7"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F11.20" codeSystem="2.16.840.1.113883.6.90" displayName="Opioid dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="2917bdac-6d83-481f-b507-17d3bf1d8282"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19480420"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="3" unit="min"/></effectiveTime>
      <routeCode code="C38284" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Nasal route"/>
      <doseQuantity value="0.1" unit="mL"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1725059" codeSystem="2.16.840.1.113883.6.88" displayName="naloxone hydrochloride 40 MG/ML Nasal Spray"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="1a94c08e-47f8-4f3f-9cdc-14ce8c3167b8"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F11.20" codeSystem="2.16.840.1.113883.6.90" displayName="Opioid dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="35d7dedd-e7d8-4230-ac8c-60da5b672eed"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19480427"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="2"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="835726" codeSystem="2.16.840.1.113883.6.88" displayName="acamprosate calcium 333 MG Delayed Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="22d0a58a-31f1-4b43-9e05-bd2fafbbb96a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F10.20" codeSystem="2.16.840.1.113883.6.90" displayName="Alcohol dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="af2b1007-a28e-40b2-bd64-a8411a7394f7"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19480420"/><high value="19481019"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="313323" codeSystem="2.16.840.1.113883.6.88" displayName="thiamine 100 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="2702f1d9-4643-434d-9602-6fa9b92daad9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="F10.20" codeSystem="2.16.840.1.113883.6.90" displayName="Alcohol dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="737c5040-85c8-4958-b213-b5dda5887818"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19480420"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="6e64fc79-6383-47ff-b307-3ef5e63f9c33"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>1948-04-27</td><td>Body height</td><td>165</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>1948-04-27</td><td>Body weight</td><td>68.2</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>1948-04-27</td><td>Body mass index (BMI) [Ratio]</td><td>25.1</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>1948-04-27</td><td>Systolic blood pressure</td><td>122</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>1948-04-27</td><td>Diastolic blood pressure</td><td>78</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>1948-04-27</td><td>Heart rate</td><td>78</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>1948-04-27</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>1948-04-27</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>1948-04-27</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="4d0d8a2c-730e-4769-9881-8808bf576373"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="19480427"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b4e423da-bbb0-4b55-b8c7-e4a2d18abcef"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="165" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ccf42f68-a1db-46c1-bdb4-4b2cc838a111"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="68.2" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="3f410032-27bf-4c34-b65b-fa6a1a8b188b"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="25.1" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b8c9948e-0339-498b-a4c3-ec920d9b4650"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="122" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a78759d6-1de0-49ae-99ab-a2565def275b"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="78" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1283fcb7-cc0e-4754-a842-9df73080fe9f"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="78" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b783aa6f-43de-44f8-90da-3a71ec7bb263"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ee3fb613-dd35-4761-b484-4b252a19dd92"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ddbc5bda-83ca-4c58-b1f8-16679d3b2cf7"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="19480427"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1948-04-27; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Alert and engaged; blood pressure 122/78, pulse 78</td></tr><tr><td>Eyes</td><td>Pupils normal in size; no yawning, tearing, or gooseflesh</td></tr><tr><td>Psychiatric</td><td>Calm; no signs of intoxication or withdrawal</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin use</td><td>active</td><td>confirmed</td>
    <td>F11.20</td><td>S — Synthetic modern coding of the documented heroin addiction; language is person-first, and the code does not change with a return to use.</td>
  </tr>
  <tr ID="problem-2">
    <td>Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother&apos;s death</td><td>active</td><td>confirmed</td>
    <td>F10.20</td><td>S — Synthetic modern coding of the documented drinking; the liver disease reported in her last year is not coded, because it was documented long after the episode.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="0ef8552f-5984-49ea-86e8-18209854608e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19480420"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ab131832-a17b-4fb7-876e-8953213b6871"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19480420"/></effectiveTime>
          <value xsi:type="CD" code="F11.20" codeSystem="2.16.840.1.113883.6.90" displayName="Opioid dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c305c482-2189-4ac5-bb1c-83e6068719ed"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19480420"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="7a1e9abb-6d0c-483f-9c9a-926c114120f0"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19480420"/></effectiveTime>
          <value xsi:type="CD" code="F10.20" codeSystem="2.16.840.1.113883.6.90" displayName="Alcohol dependence, uncomplicated"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Opioid use disorder on buprenorphine (F11.20)</content>. No opioid use, but cravings persist at 8 mg. Urine test today shows buprenorphine and its metabolite and no fentanyl or other opioids. Dr. Ortiz agrees with increasing the dose. Safety reviewed: no thoughts of suicide or self-harm; naloxone in place. [S]<list><item>Increase buprenorphine with naloxone to 16 mg (two films) once daily.</item><item>Fiber, fluids, and a stool softener as needed for constipation.</item><item>Weekly counseling and a peer recovery coach, as she chose today.</item></list></item><item><content styleCode="Bold">Alcohol use disorder (F10.20)</content>. Drinking unchanged. Naltrexone cannot be used with buprenorphine; kidney function is normal (creatinine 0.72 mg/dL), so acamprosate is suitable. [S]<list><item>Start acamprosate 666 mg three times daily.</item><item>Continue thiamine.</item><item>PEth and liver tests at the next visit.</item></list></item><item><content styleCode="Bold">Screening results</content>. Hepatitis C antibody nonreactive (signal-to-cutoff 0.09); hepatitis B surface antigen and core antibody nonreactive, and surface antibody 3 mIU/mL, so she is not immune; HIV antigen-antibody test nonreactive. AST 52 and GGT 84 U/L with ALT 38, consistent with alcohol; albumin 4.0 g/dL and bilirubin 0.7 mg/dL normal; FIB-4 1.18, below 1.3, which makes advanced fibrosis unlikely. [S]<list><item>Second hepatitis B vaccine dose at the next visit.</item><item>Repeat liver tests with PEth.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Medication safety</td><td>Buprenorphine dose, adherence, cravings, withdrawal, and side effects</td><td>Every visit</td><td>Completed today</td><td>8 mg daily, every dose taken; evening cravings; no withdrawal or sedation; increased to 16 mg</td></tr><tr><td>Self-management</td><td>Visit frequency</td><td>Every 1 to 2 weeks in the first month after starting, then every 2 to 4 weeks until stable</td><td>Completed today</td><td>Seen one week after starting</td></tr><tr><td>Laboratory</td><td>Urine drug testing, including fentanyl, explained as part of care rather than as a test of trust</td><td>At the start, then about monthly early in treatment and as needed</td><td>Completed today</td><td>Buprenorphine and norbuprenorphine present; no fentanyl or other opioids</td></tr><tr><td>Medication safety</td><td>Prescription drug monitoring program check</td><td>Before each buprenorphine prescription</td><td>Completed today</td><td>No other controlled-substance prescriptions</td></tr><tr><td>Medication safety</td><td>Naloxone at home and in her bag, and a trained companion</td><td>At the start; check and replace at each visit</td><td>Completed today</td><td>Two two-packs dispensed; her friend trained</td></tr><tr><td>Self-management</td><td>Overdose prevention: never using alone and fentanyl test strips</td><td>Every visit</td><td>Completed today</td><td>Reviewed; fentanyl test strips given</td></tr><tr><td>Self-management</td><td>Counseling and peer recovery support</td><td>Offered to everyone; not a condition of medication</td><td>Completed today</td><td>She chose weekly counseling and a peer recovery coach</td></tr><tr><td>Self-management</td><td>Oral care on sublingual buprenorphine</td><td>At the start and yearly</td><td>Completed today</td><td>After the film dissolves, swish water and swallow, and wait an hour before brushing; dental visit advised</td></tr><tr><td>Survey</td><td>Drinking and PEth</td><td>PEth at intake and at each check while drinking continues; AUDIT-C yearly</td><td>Up to date</td><td>PEth 312 ng/mL and AUDIT-C 8 a week ago; four or five drinks on performance nights</td></tr><tr><td>Medication safety</td><td>Acamprosate adherence and kidney function</td><td>Kidney function before starting; adherence every visit</td><td>Completed today</td><td>Creatinine 0.72 mg/dL and eGFR 113 a week ago; acamprosate started</td></tr><tr><td>Medication safety</td><td>Naltrexone for alcohol use disorder</td><td>First-line for alcohol use disorder unless opioids are needed</td><td>Not indicated</td><td>Contraindicated with buprenorphine</td></tr><tr><td>Examination</td><td>Alcohol withdrawal risk</td><td>Every visit</td><td>Completed today</td><td>No history of withdrawal seizures or delirium; no withdrawal symptoms</td></tr><tr><td>Medication safety</td><td>Thiamine</td><td>While drinking heavily</td><td>Completed today</td><td>Taking thiamine 100 mg daily</td></tr><tr><td>Laboratory</td><td>Liver tests (AST, ALT, GGT, albumin, bilirubin)</td><td>At intake, then every 1 to 3 months while drinking is heavy, and yearly</td><td>Up to date</td><td>AST 52, ALT 38, GGT 84 U/L a week ago; albumin and bilirubin normal</td></tr><tr><td>Laboratory</td><td>FIB-4 fibrosis score</td><td>At intake; repeat in 6 to 12 months with ongoing drinking, and every 1 to 2 years</td><td>Up to date</td><td>1.18 a week ago (age 33, AST 52, ALT 38, platelets 236): low risk</td></tr><tr><td>Imaging</td><td>Vibration-controlled transient elastography</td><td>If FIB-4 is 1.3 or higher</td><td>Not indicated</td><td>FIB-4 below 1.3</td></tr><tr><td>Laboratory</td><td>Hepatitis C, hepatitis B, and HIV testing</td><td>At entry to care, then yearly while any drug use continues</td><td>Up to date</td><td>All nonreactive a week ago</td></tr><tr><td>Self-management</td><td>Hepatitis A and B vaccines</td><td>Hepatitis B two doses 4 weeks apart; hepatitis A two doses 6 months apart</td><td>Up to date</td><td>First doses a week ago; hepatitis B dose 2 next visit</td></tr><tr><td>Survey</td><td>Depression screen (PHQ-9)</td><td>At intake and at each recovery visit while symptoms are present</td><td>Up to date</td><td>PHQ-9 9 a week ago; next at the five-week visit</td></tr><tr><td>Survey</td><td>Suicide and overdose risk review, safety plan, and the 988 Suicide &amp; Crisis Lifeline</td><td>Every visit</td><td>Completed today</td><td>No thoughts of suicide or self-harm; overdose risk lowered by buprenorphine and naloxone; the 988 Suicide &amp; Crisis Lifeline saved in her phone</td></tr><tr><td>Laboratory</td><td>Pregnancy test and contraception</td><td>Before starting buprenorphine; contraception discussed</td><td>Up to date</td><td>Urine pregnancy test negative a week ago</td></tr><tr><td>Referral</td><td>Addiction medicine consultation</td><td>At the start of treatment</td><td>Completed today</td><td>Seen by Dr. Ortiz today</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Stay on buprenorphine without interruption through six months, including through any return to use. In progress; target 1948-10-19 [S]</item><item>Naloxone at home and in her bag, and a friend trained to use it, by the one-week visit. Outcome by 1948-04-27: Two naloxone two-packs dispensed; her friend trained [S]</item><item>Reduce drinking to PEth below 20 ng/mL, or to the level she chooses, by six months. In progress; target 1948-10-19 [S]</item><item>Hepatitis A and B vaccine series completed by six months. In progress; target 1948-10-19 [S]</item><item>PHQ-9 score below 5 by six months. In progress; target 1948-10-19 [S]</item></list><paragraph>Guideline basis: The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020); Treatment Options for Substance Use Disorder (medications for opioid and alcohol use disorders) (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases (2019); AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)</paragraph><paragraph>Follow-up: Visit in two weeks; she leaves on tour in five days and will call in, with the in-person visit when she returns. Counselor weekly. Results by phone. Next scheduled visit 1948-05-26: five-week recovery review and second hepatitis B vaccine. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
